These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22834773)

  • 1. Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomography.
    Lindner J; Hillmann K; Blume-Peytavi U; Lademann J; Lux A; Stroux A; Schneider A; Garcia Bartels N
    Br J Dermatol; 2012 Dec; 167(6):1272-8. PubMed ID: 22834773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study.
    Kanti V; Nuwayhid R; Lindner J; Hillmann K; Stroux A; Bangemann N; Kleine-Tebbe A; Blume-Peytavi U; Garcia Bartels N
    Br J Dermatol; 2014 Mar; 170(3):643-50. PubMed ID: 24641211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
    Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
    Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients.
    Fonia A; Cota C; Setterfield JF; Goldberg LJ; Fenton DA; Stefanato CM
    J Am Acad Dermatol; 2017 May; 76(5):948-957. PubMed ID: 28284826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hair shaft abnormalities in alopecia areata evaluated by optical coherence tomography.
    Garcia Bartels N; Jahnke I; Patzelt A; Richter H; Lademann J; Blume-Peytavi U
    Skin Res Technol; 2011 May; 17(2):201-5. PubMed ID: 21241369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
    Protière C; Evans K; Camerlo J; d'Ingrado MP; Macquart-Moulin G; Viens P; Maraninchi D; Genre D
    Support Care Cancer; 2002 Oct; 10(7):529-37. PubMed ID: 12324807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty liver and transaminase changes with adjuvant tamoxifen therapy.
    Liu CL; Huang JK; Cheng SP; Chang YC; Lee JJ; Liu TP
    Anticancer Drugs; 2006 Jul; 17(6):709-13. PubMed ID: 16917217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
    Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A;
    Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.
    Pritchard KI; Shepherd LE; Chapman JA; Norris BD; Cantin J; Goss PE; Dent SF; Walde D; Vandenberg TA; Findlay B; O'Reilly SE; Wilson CF; Han L; Piura E; Whelan TJ; Pollak MN
    J Clin Oncol; 2011 Oct; 29(29):3869-76. PubMed ID: 21911723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and adjuvant tamoxifen treatment in breast cancer patients.
    Boehm DU; Lebrecht A; Eckhardt T; Albrich S; Schmidt M; Siggelkow W; Kandelhardt E; Koelbl H
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):500-6. PubMed ID: 19490009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
    Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
    Psychooncology; 2009 Aug; 18(8):811-21. PubMed ID: 19085975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
    Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
    Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial cancer in patients with breast carcinoma treated with tamoxifen: report of two cases and the literature overview.
    Sliwińska M; Wojtacki J; Sliwiński W
    Med Sci Monit; 2000; 6(2):399-406. PubMed ID: 11208346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinosarcoma arising in uterine didelphys after tamoxifen therapy for breast cancer: a case report.
    Suprasert P; Khunamornpong S
    J Med Assoc Thai; 2010 May; 93(5):608-12. PubMed ID: 20524448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
    Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
    Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women.
    Gradishar WJ
    Oncology; 2005; 69(1):1-9. PubMed ID: 16088229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen-induced female androgenetic alopecia in a patient with breast cancer.
    Ayoub JP; Valero V; Hortobagyi GN
    Ann Intern Med; 1997 May; 126(9):745-6. PubMed ID: 9139575
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
    ; Thürlimann B; Keshaviah A; Coates AS; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Rabaglio M; Smith I; Wardley A; Price KN; Goldhirsch A
    N Engl J Med; 2005 Dec; 353(26):2747-57. PubMed ID: 16382061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke risk and tamoxifen therapy for breast cancer.
    Geiger AM; Fischberg GM; Chen W; Bernstein L
    J Natl Cancer Inst; 2004 Oct; 96(20):1528-36. PubMed ID: 15494603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.